1. Harris, W. S., & Von Schacky, C. (2004).
The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine, 39(1), 212-220.
2. Calder, P. C. (2006).
n−3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition, 83(6), 1505S-1519S.
3. Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., ... & Stoll, A. L. (2006).
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. The Journal of Clinical Psychiatry, 67(12), 1954-1967.
4. Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., ... & Mittendorfer, B. (2011).
Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperaminoacidemia-hyperinsulinemia in healthy young and middle-aged men and women. Clinical Science, 121(6), 267-278.
5. Calder, P. C. (2010).
Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 38(1), 211-215.
6. Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006).
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis, 189(1), 19-30.